Sofie Deschoemaeker

Sofie Deschoemaeker

Sofie Deschoemaeker

Postdoctoral Scientist - Myeloid Cell Immunology Lab – VUB/VIB

Dr. Sofie Deschoemaeker currently holds a Stichting tegen Kanker post-doctoral mandate at the VUB/VIB Myeloid Cell Immunology lab in Brussels. She obtained her PhD in Biomedical sciences at the KU Leuven where her research focus was on the role of oxygen sensors in cancer. With this expertise, she continued after her PhD as scientist at DROIA Oncology Ventures to manage non-clinical development experiments of anti-cancer drugs ITPP (Normoxys) and CP-506 (Convert Pharmaceuticals). Now, Sofie, together with co-inventors Prof. Damya Laoui and Prof. Jo Van Ginderachter, is advancing the development of tumor-derived cDCs as novel cancer treatment strategy against relapse and metastasis.

Join us in person on 19 May

Flanders.bio Strategic Partners

Flanders.bio Supporting Partners